The combination of PTEN loss, with additional deletions or mutations of RB1 and TP53 have also been shown to harbor the onset metastatic castration resistant PCa (mCRPC) phenotypes in both human samples and genetically engineered mouse models. The gene discussed is RB1; the disease is posterior cortical atrophy.